http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CY-1116143-T1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F7-1804
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-277
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
filingDate 2015-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca522bcb5779e48c5bf8ccf0e0ab01ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5413e226e409227f38588245c7492003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1727ef5752aafd960da3f0e90961f5a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b26e34e7ab2e19ec80d6c796dd9374e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd9a5413eb319cfd3d50e9eb27b09bf6
publicationDate 2017-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CY-1116143-T1
titleOfInvention Chromenone derivatives with anti-cancer action
abstract The invention relates to chromenone derivatives of Formula (I) or pharmaceutically acceptable salts thereof, wherein each of R1, R2, R3, R4, R5, R6, R7, n and R8 has the meaning defined herein in the specification, processes for the their preparation, pharmaceutical compositions containing them, and their use in the manufacture of medicaments for use in the treatment of cell reproductive disorders.
priorityDate 2009-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID323
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481434

Total number of triples: 33.